跳至主要内容
临床试验/NL-OMON54875
NL-OMON54875已完成2 期

Preoperative radiotherapy in patients at very high risk of postoperative pancreatic fistula after pancreatoduodenectomy (FIBROPANC-1): a multicenter phase II study - FIBROPANC-1

Academisch Medisch Centrum0 个研究点目标入组 33 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
33

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Patients scheduled to undergo pancreatoduodenectomy for another indication
  • than pancreatic ductal adenocarcinoma.
  • - Pancreatic duct diameter < 3 millimetres, measured on the diagnostic CT scan
  • (at the level of the portomesenteric vein, at the pancreatic neck, the future
  • anastomotic site).
  • - WHO-ECOG performance status 0,1 or 2.
  • - Ability to undergo stereotactic radiotherapy and surgery.
  • - Age * 18 years.
  • - Good understanding of the oral and written patient information provided.
  • - Written informed consent.

排除标准

  • - Patients undergoing pancreatoduodenectomy for (suspected) pancreatic cancer,
  • chronic pancreatitis, or benign neoplasms (e.g. serous cyst) in the
  • periampullary region.
  • - Contra-indications for MRI (only for VUmc and UMCU), (e.g. presence of a
  • pacemaker or defibrillator, metal splinters).

研究者

相似试验